Mersana Therapeutics, Inc.
MRSN
$0.3977
-$0.0023-0.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.75% | 52.61% | -25.70% | 1.22% | 53.08% |
| Total Depreciation and Amortization | -0.50% | -0.25% | -4.73% | -5.37% | 4.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.78% | -0.73% | -8.44% | -5.98% | 19.55% |
| Change in Net Operating Assets | -538.43% | 27.32% | 89.08% | -3.61% | -100.48% |
| Cash from Operations | -124.45% | 60.75% | 33.08% | -2.17% | 30.64% |
| Capital Expenditure | -- | -- | 100.00% | 65.80% | 18.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.62% | 416.32% | 107.61% | -452.66% | -80.30% |
| Cash from Investing | 75.62% | 416.32% | 107.60% | -460.07% | -80.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9,008.70% | 51.06% | 27.69% | 1.52% | -1.54% |
| Issuance of Common Stock | -- | -100.00% | -96.61% | 3,630.38% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8,017.39% | -115.03% | -97.38% | 6,235.87% | 163.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.35% | 222.75% | 83.71% | -747.76% | -120.37% |